PharVision Advisers’s Mercury Insurance MCY Stock Holding History

PharVision Advisers’s Portfolio MCY Stock Details MCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,568	Closed	-$242K	–	425
2025 Q4	$242K	Sell	2,568 -1,422	-36%	-$123K	0.12%	417
2025 Q3	$338K	Buy	+3,990	New	+$294K	0.19%	157

Other funds holding MCY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

PharVision Advisers's MCY Position: Q1 2026 in Review

PharVision Advisers sold out of Mercury Insurance (MCY) in Q1 2026, closing a stake of 2,568 shares — an estimated $242K sold.

PharVision Advisers first reported a position in MCY in Q3 2025 and held it in 2 quarters. The position peaked at $338K in Q3 2025. 305 funds tracked by Wall St. Rank hold MCY as of Q1 2026.

PharVision Advisers reported no remaining Mercury Insurance position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 2,568 Mercury Insurance shares in Q1 2026, an estimated $242K.
PharVision Advisers first reported a position in Mercury Insurance in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Mercury Insurance position peaked at $338K in Q3 2025.
305 funds tracked by Wall St. Rank held Mercury Insurance as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.